Key result
Patients with end-stage renal disease demonstrated significantly greater cardiac fibrotic burden compared to healthy controls (16.3 vs 6.5 AU, p=0.003) using gadolinium-free MT-weighted MRI.
Why the study?
Does gadolinium-free cardiac fibrosis imaging using MT-weighted MRI correlate with structural and functional decline in patients with ESRD?
Observational (n=62)
No
Does gadolinium-free cardiac fibrosis imaging using MT-weighted MRI correlate with structural and functional decline in patients with ESRD?
Gadolinium-free magnetization transfer MRI can safely quantify cardiac fibrosis in ESRD patients and predicts longitudinal decline in ventricular contractile function.
MT-weighted MRI detects higher fibrosis in ESRD without gadolinium; hypothesis-generating for functional decline, prospective studies needed before clinical use.
Patients with end stage renal disease (ESRD) suffer high mortality from arrhythmias linked to fibrosis, but are contraindicated to late gadolinium enhancement magnetic resonance imaging (MRI). We present a quantitative method for gadolinium-free cardiac fibrosis imaging using magnetization transfer (MT) weighted MRI, and probe correlations with widely used surrogate markers including cardiac structure and contractile function in patients with ESRD. In a sub-group of patients who returned for follow-up imaging after one year, we examine the correlation between changes in fibrosis and ventricular structure/function. Quantification of changes in MT revealed significantly greater fibrotic burden in patients with ESRD compared to a healthy age matched control cohort. Ventricular mechanics, including circumferential strain and diastolic strain rate were unchanged in patients with ESRD. No correlation was observed between fibrotic burden and concomitant measures of either circumferential or longitudinal strains or strain rates. However, among patients who returned for follow up examination a strong correlation existed between initial fibrotic burden and subsequent loss of contractile function. Gadolinium-free myocardial fibrosis imaging in patients with ESRD revealed a complex and longitudinal, not contemporary, association between fibrosis and ventricular contractile function.
No takes yet. Share an insight, caveat, or question.
Stromp et al. (2018) conducted an observational in End Stage Renal Disease (ESRD) (n=62). End Stage Renal Disease vs. Healthy controls was evaluated on Global fibrotic burden (divergence) (p=0.003). Patients with end-stage renal disease demonstrated significantly greater cardiac fibrotic burden compared to healthy controls (16.3 vs 6.5 AU, p=0.003) using gadolinium-free MT-weighted MRI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: